Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)

Archived

National Institutes of Health

Description

The purpose of this Funding Opportunity Announcement (FOA) is to stimulate and support investigator-driven collaborative research to: 1) probe how vaccine elicited antibodies protect against viral acquisition via Fc receptor (FcR) mediated mechanisms; and 2) benchmark functional profiles of vaccines that protect against viral infections to inform advancement of HIV vaccine candidates. This initiative will support basic/pre-clinical research and analysis of clinical samples to evaluate parameters critical for the elicitation of protective FcR antibody effector function.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedMay 12, 2014
  • ClosesJan 7, 2017
  • CFDA93.855, 93.856
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro